Inci Ozdemir

Inci Ozdemir is a seasoned professional with a robust background in biopharmaceuticals, currently serving as Group Lead at Pfizer since June 2012. Experience includes managing diverse upstream process development portfolios involving mRNA, mammalian, and microbial cell culture platforms for biologics production from early to late phase clinical trials and commercialization. Previous roles at Pfizer as Senior Principal Scientist and Principal Scientist encompassed expertise in process development, tech transfers, and regulatory filings. Earlier career stages involved research as a Graduate Research Assistant at North Carolina State University focusing on glycoside hydrolases and an internship at Henkel in liquid detergent production. Inci Ozdemir holds a Ph.D. in Chemical and Biomolecular Engineering from North Carolina State University and a B.S. in Chemical Engineering from Orta Doğu Teknik Üniversitesi.